Last reviewed · How we verify
NCT04235751
Effect of Coaching on Surgeon Well-Being, Job Satisfaction, & Fulfillment
NA trial testing Professional Coaching in Professional Burnout in 80 participants. Completed in 15 June 2021.
30 October 2020
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 80 |
| Start date | 15 January 2020 |
| Primary completion | 30 October 2020 |
| Estimated completion | 15 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Professional Coaching
Conditions studied
- Professional Burnout — all drugs for Professional Burnout →
- Professional Stress — all drugs for Professional Stress →
- Job Stress — all drugs for Job Stress →
Sponsor
Mayo Clinic
Who can join
Eligibility, any sex, with Professional Burnout or Professional Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Researchers are trying to determine if individualized professional coaching improves physicians' sense of well-being and job satisfaction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04235751
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Professional Coaching
Trials testing the same drug.
- NCT03207581 — Effect of Coaching on Mid-Career Physician Well-Being, Job Satisfaction, and Fulfillment · NA · completed
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04235751 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 16 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04235751.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing